Navigation Links
New Clues to How HIV Infects Body's Cells
Date:8/1/2012

WEDNESDAY, Aug. 1 (HealthDay News) -- Helper T-cells normally support the immune system, but a new study involving mice shows HIV-infected T-cells help transport the virus throughout the body and infect other T-cells.

Researchers from Massachusetts General Hospital said their findings could lead to improved treatments that could help control the movement of infected T-cells in the body.

"We have found that HIV disseminates in the body of an infected individual by 'hitching a ride' on the T-cells it infects," study author Dr. Thorsten Mempel, of the Massachusetts General Hospital Center for Immunology and Inflammatory Diseases, said in a hospital news release.

The researchers examined the behavior of HIV-infected human T-cells using a "humanized" mouse model, which has an essentially human immune system, according to the release.

After confirming that human T-cells enter and migrate within the animals' lymph nodes, the researchers injected them with HIV engineered to give off a green fluorescent protein, which allowed them to monitor the movement of infected cells.

They found that within two days, the HIV-infected T-cells moved more slowly than healthy T-cells. They also were evenly distributed within the lymph node, but they remained close to the injection site.

"Infected T-cells continue doing what they usually do -- migrating within and between tissues such as lymph nodes -- and in doing so they carry HIV to remote locations that the virus could not reach as easily," Mempel said. "There are drugs that can manipulate the migration of T-cells that potentially could be used to help control the spread of virus within a patient."

Ten percent to 20 percent of the HIV-infected T-cells formed long, thin extensions that trailed behind the moving cells. These elongated cells contained the HIV envelope protein, which researchers thought might cause infected cells to "tether" to uninfected cells and form these extensions.

Infected cells had multiple nuclei, the researchers found, which shows they were formed when several cells combined.

The researchers also injected a separate group of mice with HIV. This group, however, was treated with an agent that prevents T-cells from leaving the lymph nodes.

After two months, the researchers found the levels of HIV in the animals' blood and in lymph far from the injection site were much lower than the levels of the animals not treated with the agent. They noted that the agent used to suppress the migration of infected T-cells did not reduce the level of HIV in animals that already had an established HIV infection.

"While our observation of tethering interactions between infected and uninfected ... cells suggests that HIV may be transmitted between T-cells by direct contact, we will have to clearly show this in future studies and explore how important it is relative to the transmission by free virus," said Mempel, who also is an assistant professor of medicine at Harvard Medical School in Boston.

The study was published Aug. 1 in the journal Nature. Scientists note that research with animals often fails to produce similar results in humans.

More information

The U.S. Centers for Disease Control and Prevention has more about HIV and AIDS.

-- Mary Elizabeth Dallas

SOURCE: Harvard Partners, news release, Aug. 1, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Study of half siblings provides genetic clues to autism
2. Ice Cream Headaches Might Offer Clues to Migraines
3. Research yields new clues to how brain cancer cells migrate and invade
4. Clues to Slacker Behavior Found in Brain, Study Says
5. Geisel researchers sift through junk to find colorectal cancer clues
6. New Clues to the Evolution of the Human Brain
7. Amazon Tribe Gives Clues to Heart-Healthy Lifestyles
8. Researchers at IRB Barcelona uncover new clues about the origin of cancer
9. Fossilized Teeth Hold Clues to Early Human Species Diet
10. Scientists discover new clues explaining tendon injury
11. New drug prevents spread of human prostate cancer cells
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Clues to How HIV Infects Body's Cells
(Date:6/27/2017)... ... June 27, 2017 , ... ... appointment of Mike Finnegan to the position of Executive Vice President, Sales and ... in healthcare technology, telehealth and medical device sales leadership. He has received industry ...
(Date:6/27/2017)... ... June 27, 2017 , ... ... many of the health care industry’s hospitals and provider groups, has announced that ... for select customers. Parasail Health is a San Francisco health-finance startup that has ...
(Date:6/27/2017)... ... June 27, 2017 , ... A January 18th article ... reach a staggering $6.81 billion by the year 2024 according to a new report. ... rate than those made from titanium. Los Angeles area clinic Beverly Hills Periodontics & ...
(Date:6/27/2017)... ... June 27, 2017 , ... Atmosera , ... Atmosera Managed Azure Services . The trusted, transparent, and secure solution for the ... growing customer base. Atmosera’s next generation services include integrated capabilities for public, private, ...
(Date:6/27/2017)... ... June 27, 2017 , ... Today, June 27th is ... PTSD. Yet less than 20% will receive adequate care due to lack of effective ... receive any care at all. And left untreated, veterans are at an increased risk ...
Breaking Medicine News(10 mins):
(Date:6/16/2017)... -- Exactly 50 years ago today, the Monterey Pop Festival opened ... the San Francisco "Summer of Love."  To celebrate the anniversary, ... in strategic market research portals that it will begin delivering ... Northern Light,s "Summer of Love (For Our Customers)."  ... ...
(Date:6/14/2017)... , June 14, 2017  In 2016, Embodied ... Startups pitch competition and came away with $25,000 ... is described by Forbes as "entering the life of ... Association as teaching "empathy to medical professionals in an ... was recently named a finalist for the Department of ...
(Date:6/11/2017)...  Eli Lilly and Company (NYSE: LLY ) ... of galcanezumab, an investigational treatment for the prevention of ... key secondary endpoints for galcanezumab compared to placebo at ... EVOLVE-2 and REGAIN) will be presented today at the ... Boston . "The detailed ...
Breaking Medicine Technology: